Biora Therapeutics, Inc. is incorporated in the state of Delaware.
San Diego, California
December 31
KPMG, LLP
We are traded on the OTC Markets’ OTC Pink Current Information tier under the symbol “BIOR”.
The company went public on June 19, 2020 as Progenity, Inc. and in 2022 changed its name to Biora Therapeutics, Inc.
Shares can be traded through a full-service stock brokerage of your choice.
We do not currently offer a direct stock purchase plan.
We do not currently offer a dividend or a dividend reinvestment program.
As of October 18, 2024, the company’s CUSIP is 74319F 404
Equiniti Trust Company, LLC (formerly known as American Stock Transfer & Trust, or AST) is our transfer agent and maintains records of our registered shareholders. For assistance with stock certificates, transfers, address or name change, please contact Equiniti directly at the address below.
Equiniti Trust Company LLC
6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449
(212) 936-5100
https://equiniti.com/us/ast-access/individuals/